Sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine Side Effects
Applies to sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine: intramuscular suspension.
Uncommon (0.1% to 1%): Hyperhidrosis
Rare (0.01% to 0.1%): Night sweats
Very common (10% or more): Diarrhea (up to 10.7%)
Common (1% to 10%): Nausea
Very common (10% or more): Injection site pain (up to 88.6%), injection site/localized swelling (up to 11.8%), injection site/localized redness (up to 10.4%)[Ref]
Uncommon (0.1% to 1%): Decreased appetite[Ref]
Postmarketing reports: Extremity (arm) pain[Ref]
Very common (10% or more): Headache (up to 64.9%)
Uncommon (0.1% to 1%): Lethargy
Uncommon (0.1% to 1%): Asthenia, malaise[Ref]
More about sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
1. Product Information. Pfizer-BioNTech COVID-19 Vaccine PF (SARS-CoV-2 mRNA (tozinameran) vaccine). Pfizer Inc. 2022.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.